Welcome back to Health Unlocked. In this episode, Jasen Petersen dives into the patient side of access to innovative wound care solutions like the Ion Gel, spotlighting how patients, providers, and small businesses can get involved in a rapidly evolving healthcare landscape. After exploring the infrastructural and supply-side mechanics in previous episodes, today’s conversation shifts to practical questions: How is this work being funded? Where can patients actually access these products? And what are the challenges for clinics and practitioners seeking to introduce new treatments? Jasen discusses regulatory pathways, real-world studies happening in Mexico, the importance of affordability, and creative ways ordinary businesses can support healthcare innovation like re-routing credit card processing fees to charitable foundations. Whether you’re a patient hoping for better outcomes, a clinician exploring new protocols, or simply someone curious about the future of patient-driven innovation, this episode is packed with insights you won’t want to miss.

Timestamps:

00:00 Discussing foundation's early funding

04:47 Discussing IP and community involvement

06:44 Availability of Ion Gel ZCM-25

12:38 Outsourcing for Safety and Efficiency

15:09 Insurance impact on wound care pricing

18:18 Conducting effective placebo-controlled trials

22:19 Efficacy and cost of cosmetic products

26:03 Challenges in Tracking Treatment Success

26:51 IonGel effectiveness and wound healing

33:27 Challenges with cardiogenic drug training

34:53 How cell-based treatments work

38:51 Adjusting cell dosage and frequency

42:57 Future plans for product distribution

45:53 From anecdotal evidence to medical use

“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”

Show Website - https://powerofsalutogenesis.com/

Ionic Alliance Foundation Website - https://iaf.care/

Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/

TopHealth Media Website - https://tophealth.care/

Welcome back to Health Unlocked, where we dive deep into the real-world challenges and breakthroughs in health innovation. In today’s episode, we’re joined once again by Jasen Petersen, who tackles some of the unanswered questions from previous conversations, this time pulling back the curtain on what “terrain support” actually means for patients and practitioners. We explore how the regulatory landscape shapes which claims can be made about cutting-edge products like Ion Gel, and why certain benefits remain unsaid even when the evidence is compelling. Jasen takes us through the complex process of classifying medical devices, what it means for safety and accessibility, and the strategic thinking behind spinning off development companies to advance multiple health solutions without sacrificing focus or effectiveness. Plus, we get a glimpse into how the future of funding and innovation might look, where collaboration thrives and skepticism, even from the scientific community, drives progress. Stick around for a candid, thoughtful conversation on the intersections of science, regulation, and building something truly new in health care.

Timestamps:

00:00 Discovering wound healing insights

04:24 Class 1 medical device safety

09:21 Goal of developing Class 1 device

13:15 Promoting a new wound healing gel

15:19 Prioritizing safety and funding strategies

19:24 Observing wound healing process

22:47 Focusing on wound healing startups

27:03 Valuing different components of IP

28:41 Collaborative company operations strategy

31:39 Drug development and investor milestones

36:38 Nonprofit funding strategy teaser

40:52 Community event with parade and helicopter

42:52 Large turnout for 250th Fun Run

“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”

Show Website - https://powerofsalutogenesis.com/

Ionic Alliance Foundation Website - https://iaf.care/

Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/

TopHealth Media Website - https://tophealth.care/

The conversation focused on recent developments surrounding a newly granted device patent, often referred to as the "IBAL patent." A key theme that emerged was how this patent, covering ionic cofactor matrices and essential ion delivery for local applications, is shaping the strategy of a nonprofit organization dedicated to advancing this technology across various medical and commercial fields. The discussion explored the innovative spin-out model being used to create specialized development companies for different indications such as wound healing, psoriasis, eczema, and skin cancer, each benefiting from shared intellectual property while maintaining independence.

Several points were raised, including the reasoning behind a nonprofit holding patents, the benefits and challenges of the collaborative licensing approach, and the significant impact of recent reimbursement changes in wound care markets. Listeners will also hear about opportunities for researchers, practitioners, patients, and capital partners to participate in the mission, as well as new fundraising mechanisms designed to support the ongoing expansion and accessibility of the technology.

Timestamps:

00:00 Protecting and promoting the technology

04:56 Patent Strategy for Medical Applications

08:08 Collaborative model for IP sharing

13:08 Finding the right people for niche markets

16:31 Collaborating on IP development

18:27 Early manufacturing possibilities

21:10 Ion gel benefits and cost savings

25:23 Pricing Strategy and Profitability

29:38 Support for practitioners and researchers

33:00 Promoting the podcast and fundraiser

37:19 Nonprofit collaboration for fee savings

39:15 Discussing funding challenges

“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”

Show Website - https://powerofsalutogenesis.com/

Ionic Alliance Foundation Website - https://iaf.care/

Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/

TopHealth Media Website - https://tophealth.care/